Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 10/2013

01-10-2013 | Literatur kommentiert

Optimaler Zeitpunkt für die Operation beim Rektumkarzinom nach neoadjuvanter Radiochemotherapie

Für welche Patienten wäre Warten besser?

Author: Prof. Dr. C. Petersen

Published in: Strahlentherapie und Onkologie | Issue 10/2013

Login to get access

Auszug

Perez RO, Habr-Gama A, Sao Juliao G et al (2012) Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Int J Radiat Oncol Biol Phys 84:1159–1165 …
Literature
1.
Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRef
2.
Francois Y, Nemoz CJ, Baulieux J et al (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 27:2396
3.
Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717PubMed
4.
Habr-Gama A, Perez RO, Proscurshim I et al (2006) Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10:1319–1328PubMedCrossRef
5.
Maas M, Beets-Tan R, Doenja MJ et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633–4640PubMedCrossRef
6.
Schmoll HJ, Van Cutsem E, Stein A et al (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 23:2479–2516PubMedCrossRef
7.
Valentini V, Van Stiphout RG, Lammering G et al (2011) Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 29:3163–3172PubMedCrossRef
Metadata
Title
Optimaler Zeitpunkt für die Operation beim Rektumkarzinom nach neoadjuvanter Radiochemotherapie
Für welche Patienten wäre Warten besser?
Author
Prof. Dr. C. Petersen
Publication date
01-10-2013
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 10/2013
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-013-0424-0

Other articles of this Issue 10/2013

Strahlentherapie und Onkologie 10/2013 Go to the issue

Nachruf

Zum Gedenken an Prof. Dr. Kian Ang

Literatur kommentiert

Bewertung der (Ballon-)Brachytherapie zur Teilbrustbestrahlung beim Mammakarzinom anhand aktueller Metanalysen

Original article

Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer

Original article

PRIMO: A graphical environment for the Monte Carlo simulation of Varian and Elekta linacs

Original article

Androgen receptor expression

Original article

Three-dimensional surface scanning for accurate patient positioning and monitoring during breast cancer radiotherapy